Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT
- PMID: 16824650
- DOI: 10.1016/j.neurobiolaging.2006.05.017
Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT
Abstract
This study aimed to investigate cross-sectional and longitudinal changes of regional cerebral blood flow (rCBF) in preclinical dementia using single photon emission computed tomography (SPECT). SPECT and cognitive function were investigated in 39 mild cognitive impairment (MCI) subjects and 20 age-matched controls. All subjects were followed longitudinally 19 months on average, 16 MCI subjects progressed to Alzheimer's disease (AD), who were retrospectively defined as progressive mild cognitive impairment (PMCI) at baseline and 23 MCI subjects remained stable and were defined as stable mild cognitive impairment (SMCI) at baseline. SPECT was performed both at the initial investigation and at follow-up. Image data were analyzed using multivariate analysis, SPM and volume of interest (VOI)-based analysis. Significant covariate patterns were derived, which differentiate among PMCI, SMCI and controls at baseline as well as describe the longitudinal progression of PMCI. The combined SPECT and neuropsychology increased the diagnostic accuracy of PMCI at baseline. SPECT and neuropsychological testing can be used objectively for both baseline diagnosis and to monitor changes in brain function during very early AD.
Similar articles
-
Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment.Neuroimage. 2003 Jul;19(3):1137-44. doi: 10.1016/s1053-8119(03)00168-x. Neuroimage. 2003. PMID: 12880839 Clinical Trial.
-
Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment: a qualitative and quantitative SPECT study.Acta Neurol Scand. 2006 Aug;114(2):91-6. doi: 10.1111/j.1600-0404.2006.00661.x. Acta Neurol Scand. 2006. PMID: 16867030
-
Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment.BMC Neurol. 2002 Sep 12;2:9. doi: 10.1186/1471-2377-2-9. BMC Neurol. 2002. PMID: 12227833 Free PMC article. Clinical Trial.
-
The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT.Neuroimage. 2005 Dec;28(4):1014-21. doi: 10.1016/j.neuroimage.2005.06.066. Epub 2005 Aug 29. Neuroimage. 2005. PMID: 16129627
-
Cerebral blood flow measurement by PET in hypertensive subjects as a marker of cognitive decline.J Alzheimers Dis. 2010;20(3):855-9. doi: 10.3233/JAD-2010-091324. J Alzheimers Dis. 2010. PMID: 20182039 Review.
Cited by
-
Carvacrol suppresses learning and memory dysfunction and hippocampal damages caused by chronic cerebral hypoperfusion.Naunyn Schmiedebergs Arch Pharmacol. 2020 Apr;393(4):581-589. doi: 10.1007/s00210-019-01754-8. Epub 2019 Nov 15. Naunyn Schmiedebergs Arch Pharmacol. 2020. PMID: 31729545
-
Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study.J Neurol. 2008 Sep;255(9):1344-53. doi: 10.1007/s00415-008-0897-4. Epub 2008 Aug 1. J Neurol. 2008. PMID: 18958573
-
Brain perfusion SPECT in dementia: what radiologists should know.Jpn J Radiol. 2024 Nov;42(11):1215-1230. doi: 10.1007/s11604-024-01612-5. Epub 2024 Jun 18. Jpn J Radiol. 2024. PMID: 38888851 Free PMC article. Review.
-
Metabolic brain networks in neurodegenerative disorders: a functional imaging approach.Trends Neurosci. 2009 Oct;32(10):548-57. doi: 10.1016/j.tins.2009.06.003. Epub 2009 Sep 16. Trends Neurosci. 2009. PMID: 19765835 Free PMC article. Review.
-
A review of neuroimaging biomarkers of Alzheimer's disease.Neurol Asia. 2013;18(3):239-248. Neurol Asia. 2013. PMID: 25431627 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources